Drug Trial Radar · NCT02852967
A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Mar 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
110
Actual
Start
Sep 14, 2016
Primary completion
Feb 13, 2019
Study completion Feb 13, 2019
Sponsor
- Lead sponsor
- Kadmon Corporation, LLCSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Aug 2, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, randomized, placebo-controlled, 2-period study to evaluate the safety, tolerability, and efficacy of belumosudil in adult subjects with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
Conditions
- Chronic Plaque Psoriasis
Interventions
BelumosudilDrug
PlaceboDrug
Placebo tablets matching belumosudil
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy: Percentage of Subjects With a ≥ 75% Decrease in PASI (PASI 75) at Week 16 (Double-blind Period)--LOCF and ObservedTime frame: 16 weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Alliance Dermatology and Mohs Center
Phoenix, Arizona
University of California, Irvine - Dermatology Clinical Research Center
Irvine, California
Dermatology Research Associates
Los Angeles, California
Renstar Medical Research
Ocala, Florida
Dawes Fretzin Dermatology Group
Indianapolis, Indiana
Dermatology Specialists Research
New Albany, Indiana
Dermatology Specialists Research
Louisville, Kentucky
Metro Boston Clinical Partners
Brighton, Massachusetts
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey
Sadick Research Group
New York, New York
Oregon Dermatology and Research Center
Portland, Oregon
Tennessee Clinical Research Center
Nashville, Tennessee
Suzanne Bruce and Associates
Katy, Texas
Austin Institute for Clinical Research
Pflugerville, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.